Makers Labs. — 360° view

Makers Labs, a company in the Pharmaceuticals industry, reported revenue of ₹48 crore and net profit of ₹8.53 crore for the September 2026 quarter.

Makers Labs. (NSE: MAKERSL-BE) closed at ₹255.24 on 20 Nov 2026. Its market capitalisation is ₹151 crore and it trades at 20.1 times earnings.

Share price
₹255.24 (20 Nov 2026)
Market cap
₹151 Cr (20 Nov 2026)
P/E
20.13 (20 Nov 2026)
Revenue
₹48 Cr (September 2026 quarter)
Net profit
₹9 Cr (September 2026 quarter)
ROCE
9.28% (FY26)
ROE
3.17% (FY26)
Book value
₹133 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: MAKERSL-BE

Incorporated in 1984, Makers Laboratories Ltd manufactures and markets around 200 pharma formulations.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.